tiprankstipranks
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market
ABOS
Acumen Pharmaceuticals
RESEARCH TOOLSreports
Want to see ABOS full AI Analyst Report?

Acumen Pharmaceuticals (ABOS) Income Statement

732 Followers

Acumen Pharmaceuticals Income Statement

Last quarter (Q4 2025), Acumen Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Acumen Pharmaceuticals's net income was $-25.14M. See Acumen Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -184.00K$ 0.00$ 0.00$ -169.00K$ -12.30M
Operating Expenses
$ 123.83M$ 114.02M$ 61.14M$ 45.24M$ 7.28M
Depreciation and Amortization
$ 0.00$ 178.00K$ 184.00K$ 169.00K$ 4.00K
EBITDA
$ -123.83M$ -98.08M$ -51.61M$ -42.69M$ -19.58M
Operating Income
$ -123.83M$ -114.02M$ -61.14M$ -45.24M$ -19.58M
Other Income/Expenses
$ 2.50M$ 11.69M$ 8.77M$ 2.38M$ -81.02M
Pretax Income
$ -121.33M$ -102.33M$ -52.37M$ -42.86M$ -100.61M
Net Income
$ -121.33M$ -102.33M$ -52.37M$ -42.86M$ -100.61M
Per Share Metrics
Basic EPS
$ -2.00$ -1.71$ -1.08$ -1.06$ -2.63
Diluted EPS
$ -2.00$ -1.71$ -1.08$ -1.06$ -2.63
Weighted Average Shares Outstanding
 60.56M 60.01M 48.49M 40.60M 38.27M
Weighted Average Shares Outstanding (Diluted)
 60.56M 60.01M 48.61M 40.60M 38.27M
Currency in USD

Acumen Pharmaceuticals Earnings and Revenue History